These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. Tse GM, Cheung HS, Pang LM, Chu WC, Law BK, Kung FY, Yeung DK. AJR Am J Roentgenol; 2003 Nov; 181(5):1267-72. PubMed ID: 14573418 [Abstract] [Full Text] [Related]
6. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Wärnberg F, Nordgren H, Bergkvist L, Holmberg L. Br J Cancer; 2001 Sep 14; 85(6):869-74. PubMed ID: 11556839 [Abstract] [Full Text] [Related]
7. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation. Ioachim E, Kamina S, Demou A, Kontostolis M, Lolis D, Agnantis NJ. Anticancer Res; 1999 Sep 14; 19(3A):2133-9. PubMed ID: 10470161 [Abstract] [Full Text] [Related]
8. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma. Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP. Am J Surg Pathol; 2009 Apr 14; 33(4):496-504. PubMed ID: 19047897 [Abstract] [Full Text] [Related]
9. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women. Rao AV, Mohammed WA, Ragoonanan C, Omo-Igbinomwanhia NE. West Indian Med J; 2002 Mar 14; 51(1):4-9. PubMed ID: 12089875 [Abstract] [Full Text] [Related]
10. Mucinous lesions of the breast. A pathological continuum. Weaver MG, Abdul-Karim FW, al-Kaisi N. Pathol Res Pract; 1993 Sep 14; 189(8):873-6. PubMed ID: 8302709 [Abstract] [Full Text] [Related]
11. Metallothionein expression in invasive and in situ breast carcinomas. Gallicchio LM, Flaws JA, Fowler BA, Ioffe OB. Cancer Detect Prev; 2005 Sep 14; 29(4):332-7. PubMed ID: 16122884 [Abstract] [Full Text] [Related]
12. Correspondence re: Jimenez RE, Wallis T, Tabasczka P, Visscher DW. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol 2000;13:37-45. Hugh J, Barley R, Dabbagh L. Mod Pathol; 2001 Mar 14; 14(3):263. PubMed ID: 11266538 [No Abstract] [Full Text] [Related]
13. Magnetic resonance mammography in small vs. advanced breast lesions - systematic comparison reveals significant impact of lesion size on diagnostic accuracy in 936 histologically verified breast lesions. Dietzel M, Baltzer PA, Vag T, Gröschel T, Richter C, Burmeister H, Kaiser WA. Rofo; 2011 Feb 14; 183(2):126-35. PubMed ID: 20830650 [Abstract] [Full Text] [Related]
14. Ductal carcinoma in situ within phyllodes tumour: a rare occurrence. Lim SM, Tan PH. Pathology; 2005 Oct 14; 37(5):393-6. PubMed ID: 16194856 [No Abstract] [Full Text] [Related]
17. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component. Yu KD, Wu LM, Liu GY, Wu J, Di GH, Shen ZZ, Shao ZM. Ann Surg Oncol; 2011 May 14; 18(5):1342-8. PubMed ID: 21042943 [Abstract] [Full Text] [Related]
18. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions]. Xie CM, Yin SH, Li H, Liu XW, Zhang Y, Lü YC, Zhang R, Li JP, Geng ZJ, Wu PH. Zhonghua Zhong Liu Za Zhi; 2010 Mar 14; 32(3):217-20. PubMed ID: 20450592 [Abstract] [Full Text] [Related]
19. Breast carcinoma in women 35 years and younger: a pathological study. Fernandopulle SM, Cher-Siangang P, Tan PH. Pathology; 2006 Jun 14; 38(3):219-22. PubMed ID: 16753742 [Abstract] [Full Text] [Related]
20. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies]. Edorh A, Parache RM, Migeon C, N'Sossani B, Rihn B. Pathol Biol (Paris); 1995 Sep 14; 43(7):584-9. PubMed ID: 8570262 [Abstract] [Full Text] [Related] Page: [Next] [New Search]